Shares of Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) rose 19.1% during mid-day trading on Thursday . The company traded as high as $0.48 and last traded at $0.48. Approximately 271 shares traded hands during trading, a decline of 86% from the average daily volume of 1,921 shares. The stock had previously closed at $0.40.
Zelira Therapeutics Stock Up 0.9 %
The firm has a fifty day moving average price of $0.39 and a 200 day moving average price of $0.45.
Zelira Therapeutics Company Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Read More
- Five stocks we like better than Zelira Therapeutics
- What is a buyback in stocks? A comprehensive guide for investors
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
